Advertising as a Signaling Device in the Swedish Pharmaceuticals Market

Jörgen Hellström () and Niklas Rudholm ()
Additional contact information
Jörgen Hellström: Department of Economics, Umeå University, Postal: S 901 87 Umeå, Sweden
Niklas Rudholm: Department of Economics, Umeå University, Postal: S 901 87 Umeå, Sweden

No 612, Umeå Economic Studies from Umeå University, Department of Economics

Abstract: The paper empirically studies whether pharmaceutical firms uses advertising as a signal for high quality drugs. A nested random effects count data hurdle model is introduced to handle the excess number of zero observations in the sample as well as nested random drug, firm and substance specific effects. The empirical study indicate that drug quality (measured as the number of side-effects) do not influence pharmaceutical firms decision to advertise or not, but do affect the number of ads in a given period. The higher quality of the drug the more ads.

Keywords: Signaling; pharmaceutical industry; advertising; product quality; nested random effects; count data (search for similar items in EconPapers)
JEL-codes: L15 L21 (search for similar items in EconPapers)
Pages: 14 pages
Date: 2003-08-26
New Economics Papers: this item is included in nep-eec and nep-ind
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.econ.umu.se/DownloadAsset.action?conten ... Id=3&assetKey=ues612 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hhs:umnees:0612

Access Statistics for this paper

More papers in Umeå Economic Studies from Umeå University, Department of Economics Department of Economics, Umeå University, S-901 87 Umeå, Sweden. Contact information at EDIRC.
Bibliographic data for series maintained by David Skog ().